Skip to main content

BRIEF-Zynerba Pharma Q1 loss per share $0.49

* Expects that existing cash and cash equivalents will fund its research and development programs and operations through 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.